Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1038/s41416-020-01194-9 http://scihub22266oqcxt.onion/10.1038/s41416-020-01194-9 33268817!7960985!33268817     free     free     free Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Br+J+Cancer 2021 ; 124 (6): 1035-1036 Nephropedia Template TP {{tp|p=33268817|t=2021. Phosphatase, pseudo-phosphatase, or both? Understanding PRL oncogenicity |pdf=|usr=}}{{33268817}} gab.com Text Phosphatase, pseudo-phosphatase, or both Understanding PRL oncogenicity JO: Br J Cancer http://www.kidney.de/pget.php?&tw=1&pmid=33268817 #FOAvip Phosphatases of regenerating liver (PRL1-3) are among the most oncogenic protein phosphatases but their mechanism of action is poorly understood. Multiple substrates have been proposed as well as a non-catalytic function regulating magnesium transport. Our recent identification of a catalytically inactive PRL mutant that retains oncogenicity in a mouse model promises to resolve the question of whether PRLs act as phosphatases or pseudo-phosphatases in different cancer models. Twit Text FOAVip Phosphatase, pseudo-phosphatase, or both Understanding PRL oncogenicity ????Br J Cancer http://www.kidney.de/pget.php?&tw=1&pmid=33268817 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33268817 #FOAvip English Wikipedia <ref>{{Cite pmid|33268817}}</ref> Phosphatase, pseudo-phosphatase, or both? Understanding PRL oncogenicity #MMPMID33268817 Gehring K; Miki H Br J Cancer 2021[Mar]; 124 (6): 1035-1036 PMID33268817show ga Phosphatases of regenerating liver (PRL1-3) are among the most oncogenic protein phosphatases but their mechanism of action is poorly understood. Multiple substrates have been proposed as well as a non-catalytic function regulating magnesium transport. Our recent identification of a catalytically inactive PRL mutant that retains oncogenicity in a mouse model promises to resolve the question of whether PRLs act as phosphatases or pseudo-phosphatases in different cancer models. |*Oncogene Proteins[MESH] |*Protein Tyrosine Phosphatases[MESH] |Animals[MESH]Phosphatase, pseudo-phosphatase, or both? Understanding PRL oncogenici(epmc).pdf DeepDyve Pubget Overpricing